Pernix Therapeutics (PTX), the Woodlands-based manager of a portfolio of branded phamaceutical products, announced their Q1 financial results for 2013. While Pernix’s net revenue increase was nearly double the numbers reported in the first quarter of 2012, the company also reported a net loss this quarter whereas they had a net income of $1.2 million in the first quarter of 2012. The reported net loss of $8.1 million was also up from the numbers reported for Pernix Therapeutic’s fourth quarter financial results for 2012.
http://bionews-tx.com/news/2013/05/14/texas-pernix-therapeutics-first-quarter-2013-financial-results-are-in/
No comments:
Post a Comment